- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Xeris Biopharma Holdings (NASDAQ:XERS), Quotes and News Summary
Xeris Biopharma Holdings (NASDAQ: XERS)
Earnings
see more| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-12-20 | ||||||
| REV | |||||||
| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-11-09 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Xeris Biopharma Holdings Questions & Answers
You can purchase shares of Xeris Biopharma Holdings (NASDAQ: XERS) through any online brokerage.
Other companies in Xeris Biopharma Holdings’s space includes: WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY), Satsuma Pharmaceuticals (NASDAQ:STSA), Rani Therapeutics Hldgs (NASDAQ:RANI) and Phathom Pharmaceuticals (NASDAQ:PHAT).
The latest price target for Xeris Biopharma Holdings (NASDAQ: XERS) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting XERS to rise to within 12 months (a possible 113.90% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Xeris Biopharma Holdings (NASDAQ: XERS) is $1.87 last updated August 12, 2022, 8:00 PM UTC.
The next Xeris Biopharma Holdings (XERS) dividend date is projected to be Thursday, September 1, 2022.
Xeris Biopharma Holdings’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Xeris Biopharma Holdings.
Xeris Biopharma Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.